Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion
BENGALURU (Reuters) – Drugmaker Granules India posted a 1.6% fall in fourth-quarter revenue on Wednesday, hurt by a decline in paracetamol sales and price erosion. The company’s consolidated revenue fell year-on-year to 11.76 billion rupees (nearly $141 million) for the three months to March 31. Granules, which focuses on making active pharmaceutical ingredients (API), holds …
Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion Read More »